How Regaining Full Rights to Rett Syndrome Gene Therapy Has Changed Taysha (TSHA)’s Investment Story
Recently, Taysha Gene Therapies announced it has regained full rights to its lead gene therapy candidate TSHA-102 for…
Sarepta Refused FDA’s Request to Halt Elevidys Shipments
(Bloomberg) — Sarepta Therapeutics Inc. has refused to pause all shipments of its Elevidys treatment after three deaths…